| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |